<!DOCTYPE html><html><head><title> Pacifica Code Section 58-85-S106 </title><link rel="stylesheet" href="/assets/style.css"/></head><body>
<b><i>
                      Effective 4/22/2020</i></b>
<br>
<b>58-85-106.&nbsp;
          </b><b>Use of investigational drugs and devices during a major public health emergency -- Limitations -- Immunity.</b>
<br>
<a id="58-85-106(1)" name="58-85-106(1)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(1)</td><td style="width:99%">
As used in this section:
<a id="58-85-106(1)(a)" name="58-85-106(1)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
"Declared major public health emergency" means a state of emergency declared by the governor under Section <a href="../../Title53/Chapter2A/53-2a-S206.html?v=C53-2a-S206_1800010118000101">53-2a-206</a> as the result of a major public health emergency.</td>
</tr>
</tbody></table>
<a id="58-85-106(1)(b)" name="58-85-106(1)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
"Health care provider" means the same as that term is defined in Section <a href="../../Title78B/Chapter3/78B-3-S403.html?v=C78B-3-S403_2019051420190514">78B-3-403</a>.</td>
</tr>
</tbody></table>
<a id="58-85-106(1)(c)" name="58-85-106(1)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
"Insurer" means the same as that term is defined in Section <a href="../../Title31A/Chapter22/31A-22-S634.html?v=C31A-22-S634_1800010118000101">31A-22-634</a>.</td>
</tr>
</tbody></table>
<a id="58-85-106(1)(d)" name="58-85-106(1)(d)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(d)</td><td style="width:99%">
"Major public health emergency" means an occurrence of imminent threat of an illness or health condition that:<a id="58-85-106(1)(d)(i)" name="58-85-106(1)(d)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
is believed to be caused by:
<a id="58-85-106(1)(d)(i)(A)" name="58-85-106(1)(d)(i)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
bioterrorism;</td>
</tr>
</tbody></table>
<a id="58-85-106(1)(d)(i)(B)" name="58-85-106(1)(d)(i)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
the appearance of a novel or previously controlled or eradicated infectious agent or biological toxin;</td>
</tr>
</tbody></table>
<a id="58-85-106(1)(d)(i)(C)" name="58-85-106(1)(d)(i)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
a natural disaster;</td>
</tr>
</tbody></table>
<a id="58-85-106(1)(d)(i)(D)" name="58-85-106(1)(d)(i)(D)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(D)</td><td style="width:99%">
a chemical attack or accidental release; or</td>
</tr>
</tbody></table>
<a id="58-85-106(1)(d)(i)(E)" name="58-85-106(1)(d)(i)(E)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(E)</td><td style="width:99%">
a nuclear attack or accident; and</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-85-106(1)(d)(ii)" name="58-85-106(1)(d)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
poses a high probability of:
<a id="58-85-106(1)(d)(ii)(A)" name="58-85-106(1)(d)(ii)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
a large number of deaths in the affected population;</td>
</tr>
</tbody></table>
<a id="58-85-106(1)(d)(ii)(B)" name="58-85-106(1)(d)(ii)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
a large number of serious or long-term disabilities in the affected population; or</td>
</tr>
</tbody></table>
<a id="58-85-106(1)(d)(ii)(C)" name="58-85-106(1)(d)(ii)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
widespread exposure to an infectious or toxic agent that poses a significant risk of substantial future harm to a large number of people in the affected population.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-85-106(1)(e)" name="58-85-106(1)(e)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(e)</td><td style="width:99%">
"Physician" means the same as that term is defined in Section <a href="../../Title58/Chapter67/58-67-S102.html?v=C58-67-S102_2017050920180701">58-67-102</a>.</td>
</tr>
</tbody></table>
<a id="58-85-106(1)(f)" name="58-85-106(1)(f)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(f)</td><td style="width:99%">
"Qualified patient" means a patient who has been diagnosed with a condition that has resulted in a declared major public health emergency.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-85-106(2)" name="58-85-106(2)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(2)</td><td style="width:99%"><a id="58-85-106(2)(a)" name="58-85-106(2)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
To the extent permitted under federal law, a qualified patient may obtain an investigational drug through an agreement with the investigational drug's manufacturer and the qualified patient's physician that provides:<a id="58-85-106(2)(a)(i)" name="58-85-106(2)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
for the transfer of the investigational drug from the manufacturer to the physician; and</td>
</tr>
</tbody></table>
<a id="58-85-106(2)(a)(ii)" name="58-85-106(2)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
that the physician will administer the investigational drug to the qualified patient.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-85-106(2)(b)" name="58-85-106(2)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
To the extent permitted under federal law, a qualified patient may obtain an investigational device through an agreement with the investigational device's manufacturer and the qualified patient's physician that provides:<a id="58-85-106(2)(b)(i)" name="58-85-106(2)(b)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
for the transfer of the investigational device from the manufacturer to the physician; and</td>
</tr>
</tbody></table>
<a id="58-85-106(2)(b)(ii)" name="58-85-106(2)(b)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
that the physician will use the investigational device to treat the qualified patient.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-85-106(2)(c)" name="58-85-106(2)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
The agreement described in Subsection <a href="#58-85-106(2)(a)">(2)(a)</a> or <a href="#58-85-106(2)(b)">(b)</a> shall include an informed consent document that, based on the physician's knowledge of the relevant investigational drug or investigational device:<a id="58-85-106(2)(c)(i)" name="58-85-106(2)(c)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
describes the possible positive and negative outcomes the qualified patient could experience if the physician treats the qualified patient with the investigational drug or investigational device;</td>
</tr>
</tbody></table>
<a id="58-85-106(2)(c)(ii)" name="58-85-106(2)(c)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
states that an insurer is not required to cover the cost of providing the investigational drug or investigational device to the qualified patient;</td>
</tr>
</tbody></table>
<a id="58-85-106(2)(c)(iii)" name="58-85-106(2)(c)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
states that, subject to Subsection <a href="#58-85-106(5)">(5)</a>, an insurer may deny coverage for the qualified patient; and</td>
</tr>
</tbody></table>
<a id="58-85-106(2)(c)(iv)" name="58-85-106(2)(c)(iv)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iv)</td><td style="width:99%">
states that the qualified patient may be liable for all expenses caused by the physician treating the patient with the investigational drug or investigational device, unless the agreement provides otherwise.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-85-106(3)" name="58-85-106(3)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(3)</td><td style="width:99%">
The physician of a qualified patient shall notify the qualified patient's insurer of:
<a id="58-85-106(3)(a)" name="58-85-106(3)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
the day on which the physician treated the qualified patient with an investigational drug or investigational device; and</td>
</tr>
</tbody></table>
<a id="58-85-106(3)(b)" name="58-85-106(3)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
the investigational drug or investigational device used under an agreement described in Subsection <a href="#58-85-106(2)">(2)</a>.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-85-106(4)" name="58-85-106(4)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(4)</td><td style="width:99%"><a id="58-85-106(4)(a)" name="58-85-106(4)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
It is not a breach of the applicable standard of care for a health care provider to treat a qualified patient with an investigational drug or investigational device under this section.</td>
</tr>
</tbody></table>
<a id="58-85-106(4)(b)" name="58-85-106(4)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
A health care provider that treats a qualified patient with an investigational drug or investigational device in accordance with this section is not subject to civil liability, criminal liability, or sanctions against the health care provider's license for any harm to the qualified patient resulting from the qualified patient's use of the investigational drug or device.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-85-106(5)" name="58-85-106(5)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(5)</td><td style="width:99%"><a id="58-85-106(5)(a)" name="58-85-106(5)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
This section does not:<a id="58-85-106(5)(a)(i)" name="58-85-106(5)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
require a manufacturer of an investigational drug or investigational device to agree to make an investigational drug or investigational device available to a qualified patient or a qualified patient's physician;</td>
</tr>
</tbody></table>
<a id="58-85-106(5)(a)(ii)" name="58-85-106(5)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
require a physician to agree to:
<a id="58-85-106(5)(a)(ii)(A)" name="58-85-106(5)(a)(ii)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
administer an investigational drug to a qualified patient under this section; or</td>
</tr>
</tbody></table>
<a id="58-85-106(5)(a)(ii)(B)" name="58-85-106(5)(a)(ii)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
treat a qualified patient with an investigational device under this section;</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-85-106(5)(a)(iii)" name="58-85-106(5)(a)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
create a private right of action for a qualified patient against a health care provider for the health care provider's refusal to:
<a id="58-85-106(5)(a)(iii)(A)" name="58-85-106(5)(a)(iii)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
administer an investigational drug to a qualified patient under this section; or</td>
</tr>
</tbody></table>
<a id="58-85-106(5)(a)(iii)(B)" name="58-85-106(5)(a)(iii)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
treat a qualified patient with an investigational device under this section; or</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-85-106(5)(a)(iv)" name="58-85-106(5)(a)(iv)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iv)</td><td style="width:99%">
create a private right of action for a qualified patient against a manufacturer for the manufacturer's refusal to provide a qualified patient with an investigational drug or an investigational device under this section.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-85-106(5)(b)" name="58-85-106(5)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
This section does not:<a id="58-85-106(5)(b)(i)" name="58-85-106(5)(b)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
require an insurer to cover the cost of:
<a id="58-85-106(5)(b)(i)(A)" name="58-85-106(5)(b)(i)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
administering an investigational drug under this section; or</td>
</tr>
</tbody></table>
<a id="58-85-106(5)(b)(i)(B)" name="58-85-106(5)(b)(i)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
treating a patient with an investigational device under this section; or</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-85-106(5)(b)(ii)" name="58-85-106(5)(b)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
prohibit an insurer from covering the cost of:
<a id="58-85-106(5)(b)(ii)(A)" name="58-85-106(5)(b)(ii)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
administering an investigational drug under this section; or</td>
</tr>
</tbody></table>
<a id="58-85-106(5)(b)(ii)(B)" name="58-85-106(5)(b)(ii)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
treating a patient with an investigational device under this section.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-85-106(5)(c)" name="58-85-106(5)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
Except as described in Subsection <a href="#58-85-106(5)(d)">(5)(d)</a>, an insurer may deny coverage to a qualified patient who is treated with an investigational drug or investigational device for harm to the qualified patient caused by the investigational drug or investigational device.</td>
</tr>
</tbody></table>
<a id="58-85-106(5)(d)" name="58-85-106(5)(d)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(d)</td><td style="width:99%">
An insurer may not deny coverage to a qualified patient under Subsection <a href="#58-85-106(5)(c)">(5)(c)</a> for:<a id="58-85-106(5)(d)(i)" name="58-85-106(5)(d)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
the qualified patient's preexisting condition;</td>
</tr>
</tbody></table>
<a id="58-85-106(5)(d)(ii)" name="58-85-106(5)(d)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
benefits that commenced before the day on which the qualified patient was treated with the investigational drug or investigational device; or</td>
</tr>
</tbody></table>
<a id="58-85-106(5)(d)(iii)" name="58-85-106(5)(d)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
palliative or hospice care for a qualified patient that has been treated with an investigational drug or investigational device but is no longer receiving curative treatment with the investigational drug or investigational device.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<br>
<br>Enacted by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=8&amp;sess=2020S3">8</a>, 2020 Special Session 3<br>
</body></html>